|
|
Vaccine Detail
|
Brucella Omp19 SodC recombinant vector vaccine |
| Vaccine Information |
- Vaccine Name: Brucella Omp19 SodC recombinant vector vaccine
- Target Pathogen: Brucella spp.
- Target Disease: Brucellosis
- Vaccine Ontology ID: VO_0009590
- Type: Recombinant vector vaccine
- Status: Research
- Host Species for Licensed Use: Human
- Host Species as Laboratory Animal Model: Vero cells
- Antigen: OMP19; SODC
- Preparation: Recombinant capripoxvirus SPPV (TK-) expressing OMP19 and SODC antigens cultivated in Vero cells using BelloStage‚Ñ¢-3000 bioreactor with BioNOC II® macrocarriers. (Amanova et al, 2025)
- Description: The study aims to develop a new human brucellosis vaccine using recombinant capripoxvirus vectors expressing Brucella antigens. (Amanova et al, 2025)
|
| Host Response |
|
|
| References |
Amanova et al, 2025: Amanova Z, Sametova Z, Chervyakova O, Turyskeldi S, Kurmasheva A, Abitayev R, Ussembay A, Kondibayeva Z, Toktyrova D, Mazbayeva D, Bulatov Y. BelloStage™-3000 Bioreactor Versus Conventional Cultivation of Recombinant Capripoxvirus Expressing Brucella Antigens in Vero Cells: A Step Towards the Development of a New Human Brucellosis Vaccine. Cells. 2025 Oct 20; 14(20); . [PubMed: 41148846].
|
|
